台股 » 生展 » 個股財報 » 每月營收

生展

(8279)
  • 股價
    158.5
  • 漲跌
    ▼1.5
  • 漲幅
    -0.94%
  • 成交量
    10
  • 產業
    上櫃 生技醫療類股 ▼0.10%
  • 本地時間:13:30(已收盤)

    67人加入追蹤

    立即追蹤

生展 (8279) 財務報表-每月營收
月營收報表

因應IFRSs國際會計準則,本報表在2013年以前為「個別營收」,2013年以後為「合併營收」。

生展 (8279) 月營收分析比較圖

生展 (8279) 月營收報表

年度/月份營業收入(單位:千元)累計營業收入(單位:千元)
單月營收去年同月營收單月月增率單月年增率累計營收去年累計營收累積年增率
2024/02150,000137,279-5.7%9.3%309,022271,68113.7%
2024/01159,022134,4022.7%18.3%159,022134,40218.3%
2023/12154,848171,140-0.3%-9.5%1,837,1851,930,594-4.8%
2023/11155,343179,2172.6%-13.3%1,682,3371,759,454-4.4%
2023/10151,410164,524-0.2%-8%1,526,9941,580,237-3.4%
2023/09151,789181,889-10.4%-16.5%1,375,5841,415,713-2.8%
2023/08169,420177,77612.8%-4.7%1,223,7951,233,824-0.8%
2023/07150,138182,456-3.5%-17.7%1,054,3751,056,048-0.2%
2023/06155,625186,4445.8%-16.5%904,237873,5923.5%
2023/05147,032176,414-6.6%-16.6%748,612687,1488.9%
2023/04157,477132,051-8.7%19.3%601,580510,73417.8%
2023/03172,422135,76125.6%27%444,103378,68317.3%
2023/02137,279104,7262.1%31.1%271,681242,92211.8%
2023/01134,402138,196-21.5%-2.7%134,402138,196-2.7%
2022/12171,140154,658-4.5%10.6%1,930,5941,471,26631.2%
2022/11179,217140,9048.9%27.2%1,759,4541,316,60833.6%
2022/10164,524136,730-9.5%20.3%1,580,2371,175,70434.4%
2022/09181,889120,3432.3%51.1%1,415,7131,038,97436.3%
2022/08177,776122,506-2.6%45.1%1,233,824918,63134.3%
2022/07182,456106,458-2.1%71.4%1,056,048796,12532.6%
2022/06186,444111,4785.7%67.2%873,592689,66726.7%
2022/05176,414148,81433.6%18.5%687,148578,18918.8%
2022/04132,051123,970-2.7%6.5%510,734429,37518.9%
2022/03135,761116,71829.6%16.3%378,683305,40524%
2022/02104,72685,119-24.2%23%242,922188,68728.7%
2022/01138,196103,568-10.6%33.4%138,196103,56833.4%
2021/12154,658117,7469.8%31.3%1,471,2661,311,43612.2%
2021/11140,904108,8203%29.5%1,316,6081,193,69010.3%
2021/10136,730106,00613.6%29%1,175,7041,084,8708.4%
2021/09120,343113,409-1.8%6.1%1,038,974978,8646.1%
2021/08122,506105,41415.1%16.2%918,631865,4556.1%
2021/07106,458122,233-4.5%-12.9%796,125760,0414.7%
2021/06111,478123,632-25.1%-9.8%689,667637,8088.1%
2021/05148,814120,09120%23.9%578,189514,17612.4%
2021/04123,970126,4076.2%-1.9%429,375394,0858.9%
2021/03116,718109,79237.1%6.3%305,405267,67814.1%
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
〈聯合再生展望〉洪傳獻:TOPCon技術明年成主流 獲利表現佳Anue鉅亨-2023/10/16
生展 相關文章